… In this retrospective study, the clinical profiles of patients carrying healthcare-associated
ESBL-producing Enterobacteriacae is characterized by a high prevalence rate of several major …

… -blactams, means that selection pressure should favor those ESBLs that are highly active
against b-lactams and … profile of cefepime against extended-spectrum-b-lactamase–producing …

… profile of various clinical isolates. erefore, this study aimed to deliver the indication of different
resistant profiles of clinically … rate of extended-spectrum beta-lactamase (ESBL), multidrug-…

… The aim of this study was to determine the current prevalence, clinical and laboratory profile
of ESBL producing E. coli and K. Pneumonia infections among uropathogenes isolated from …

… Strengths of our study include its multicenter nature, clinical … could not compare the ESBLEC
profiles with a control group … identified according to their virulence profile were identified and …

… OXA enzymes have more than 50% hydrolytic activity against cloxacillin or oxacillin compared
with that against benzylpenicillin and variable inhibition profile by β-lactamase inhibitors […

… PROFILES Substrate profiles indicating the range of ,B-… definitive characteristics of 13-lactamases.
For many antibiotics, hy… P-lactamases that are now being identified after clinical use of …

… beta-lactamase producing Klebsiella pneumoniae (ESBL-KP) worldwide including India,
which is a major concern for the clinicians, … -KP and antimicrobial sensitivity profile to plan a …

… is by grouping these enzymes according to their clinical role. This functional classification, …
all the known beta-lactamases into five major groups based on their substrate profile. Sykes …

… sensitivity profile of ESBL producing E. coli isolates from various clinical samples. …
chromosomally mediated β-lactamase or plasmid mediated β-lactamases. These enzymes are …